Today’s Ocular Surface Disease: Optimizing Your Diagnosis, Diagnostics, and Therapeutic Approach
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Overview
Jointly sponsored by the Dulaney Foundation and Cataract & Refractive Surgery Today. This continuing medical educational activity is supported by an unrestricted educational grant from Allergan, Inc. Release date: September 2014. Expiration date: September 2015.Supported by an unrestricted educational grant from Allergan, Inc. A CME activity jointly sponsored by the Dulaney Foundation and Cataract & Refractive Surgery Today Learning Objectives
Upon completion of this activity, participants should be able to: • Diagnose acute dry eye conditions and chronic ocular surface disease • Identify patient groups at risk for ocular surface disease in the practice • Recognize the chronic nature and inflammatory processes in ocular surface disease • Understand new ocular surface disease diagnostic technologies • Differentiate palliative versus therapeutic treatment of ocular surface disease • Discuss the impact of ocular surface disease on surgical outcomes Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dulaney Foundation and Cataract & Refractive Surgery Today. The Dulaney Foundation is accredited by the ACCME to provide continuing education for physicians. The Dulaney Foundation designates this print activity for a maximum of 1 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participation Method
Participants should read the CME activity in its entirety. After reviewing the material, please complete the self-assessment test, which consists of a series of multiple-choice questions. To answer these questions online and receive real-time results, please visit http://www.eyetube.net/cmecenter/ and click on the icon with this activity’s title. You will be redirected to http://www.dulaneyfoundation.org where you will log in and complete the activity. Upon completing the activity and achieving a passing score of over 70% on the self-assessment test, you may print out a CME credit letter awarding 1 AMA PRA Category 1 Credit.™ The estimated time to complete this activity is 1 hour. Faculty and Disclosures
DISCLOSURE POLICY
Faculty Credentials Christopher E. Starr, MD (Moderator), is an associate professor of ophthalmology; director of refractive surgery service; director of cornea, cataract & refractive surgery fellowship; and director of ophthalmic education at Weill Cornell Medical College, New York Presbyterian Hospital in New York City. Dr. Starr may be reached at cestarr@med.cornell.edu. Terry Kim, MD, is a professor of ophthalmology at Duke University Eye Center in Durham, North Carolina. Dr. Kim may be reached at (919) 681-3568; terry.kim@duke.edu. Marguerite B. McDonald, MD, is a corneal/refractive specialist with Ophthalmic Consultants of Long Island in New York, a clinical professor of ophthalmology at the NYU School of Medicine in New York, and an adjunct clinical professor of ophthalmology at the Tulane University Health Sciences Center in New Orleans. Dr. McDonald may be reached at (516) 593-7709; margueritemcdmd@aol.com. William B. Trattler, MD, is the director of cornea at the Center for Excellence in Eye Care in Miami. Dr. Trattler may be reached at (305) 598-2020; wtrattler@earthlink.net. Darrell E. White, MD, is the president and CEO of Sky Vision Center in Cleveland. Dr. White may be reached at (440) 892-3931; they@skyvisioncenters.com. Faculty/Staff Disclosures Christopher E. Starr, MD, has had a financial agreement or affiliation during the past year with the following commercial interests: Alcon Laboratories, Inc.; Allergan, Inc.; Bausch & Lomb Incorporated; Merck & Co. Inc.; Rapid Pathogen Screening, Inc.; and TearLab Corporation. Terry Kim, MD, has had a financial agreement or affiliation during the past year with the following commercial interest: Alcon Laboratories, Inc.; Bausch & Lomb Incorporated; Ocular Systems Inc.; Ocular Therapeutix, Inc.; Omerus; PowerVision, Inc.; Shire; and TearScience, Inc. Marguerite B. McDonald, MD, has had a financial agreement or affiliation during the past year with the following commercial interests: Abbott Medical Optics Inc.; Allergan, Inc.; Bausch & Lomb Incorporated; Nexis Vision Group; OCuSOFT; TearLab Corporation; and TearScience, Inc. William B. Trattler, MD, has had a financial agreement or affiliation during the past year with the following commercial interests: Abbott Medical Optics Inc.; Allergan, Inc.; Bausch & Lomb Incorporated; and CXL Ophthalmolics, LLC. Darrell E. White, MD, has had a financial agreement or affiliation during the past year with the following commercial interests: Allergan, Inc.; Bausch & Lomb Incorporated; Eyemaginations, Inc.; and Nicox, Inc. All of those involved in the planning, editing, and peer review of this educational activity report no relevant financial relationships. Disclosure Policy In accordance with the disclosure policies of the Dulaney Foundation and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices or providers of commercial services and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the Dulaney Foundation, Cataract & Refractive Surgery Today, and Allergan, Inc. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Andrew R. Harrison, MD
Kian Eftekhari, MD
Andrew G. Lee, MD
Wendy W. Lee, MD
Nicholas Robert Mahoney, MD
Amina Malik, MD
Prem S. Subramanian, MD, PhD
Jeremiah Tao, MD, FACS
- CME/CE Broadcast Replay
KOL KNOCKOUT™: Oculoplastics Edition – Sculpting Sight For Patients With Thyroid Eye Disease - Round 3
1.00 creditAndrew R. Harrison, MD
Andrew G. Lee, MD
Wendy W. Lee, MD
Nicholas Robert Mahoney, MD
Blake K. Williamson, MD, MPH, MS
Brett Mueller, DO, PhD
Taj Nasser, MD
Julie Marie Schallhorn, MD, MS
Evan D. Schoenberg, MD
F. Beau Swann, MD, MS
Rahul S. Tonk, MD, MBA
William F. Wiley, MD
- CME/CE Broadcast Replay
KOL Knockout™ - Cataract Edition: More than Best Corrected Visual Acuity: Meeting Patient Refractive Expectations - Round 2
1.50 creditsBlake K. Williamson, MD, MPH, MS
Brett Mueller, DO, PhD
Taj Nasser, MD
Evan D. Schoenberg, MD
